Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication. Sasaki-Tanaka R, Masuzaki R, Okamoto H, Shibata T, et al. J Virol 2023 Feb 2:e0198722. doi: 10.1128/jvi.01987.

Read + Share

Amedeo Smart

Independent Medical Education

Sasaki-Tanaka R, Masuzaki R, Okamoto H, Shibata T, et al. Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication. J Virol 2023 Feb 2:e0198722. doi: 10.1128/jvi.01987.
PMID: 36728416